Semaglutide Weight Loss Per Week: A Realistic, Clinical Breakdown

At therapeutic doses, most people on semaglutide lose between 0.5 and 1.5 pounds per week. The STEP 1 clinical trial found an average total body weight loss of 14.9 percent over 68 weeks, which works out to roughly 0.5 to 0.7 pounds per week across the full treatment period. Results vary by individual, starting weight, dose, and dietary habits.

If you are on semaglutide, one of the first things you do is watch the scale more closely than you expected. That is normal. You want to know whether what you are seeing is reasonable progress or a sign that something is off. This guide walks you through what the clinical data actually says, what each phase of treatment typically looks like, and how to estimate your own realistic weekly target.

What the Clinical Trials Actually Show

The most referenced study on semaglutide for weight loss is the STEP 1 trial, published in the New England Journal of Medicine in 2021. This 68-week trial enrolled nearly 2,000 adults with a BMI of 30 or above, all receiving 2.4 mg of semaglutide weekly alongside lifestyle guidance.

Participants lost an average of 14.9 percent of their total body weight over 68 weeks, compared to 2.4 percent in the placebo group. For someone starting at 220 pounds, that average response equals roughly 33 pounds lost, or approximately 0.5 to 0.7 pounds per week.

The STEP 3 trial, which added more intensive behavioral support alongside semaglutide, pushed the average to 16 percent. That finding matters because it shows the medication works best when paired with intentional dietary changes, not as a standalone solution.

The range of individual responses in STEP 1 was also significant. Around half of participants lost more than 15 percent of their body weight. About one in three lost more than 20 percent. Top responders lost upward of 25 percent. The lower end of the range was 5 to 8 percent. Where you land depends on your biology, your diet, and the consistency of your protocol.

The Semaglutide Timeline: What Each Phase Actually Feels Like

One of the most common early frustrations on semaglutide is expecting immediate results and feeling discouraged when the scale moves slowly in the first few weeks. Here is what each phase typically looks like and why.

Weeks 1 to 4: The Adjustment Phase (0.25 mg Weekly)

The first month is not designed for rapid weight loss. The 0.25 mg starting dose exists to let your body build tolerance to the medication and minimize side effects, particularly nausea. Most people lose between 2 and 5 pounds during this window, primarily from eating slightly less. Do not judge the medication based on this phase.

Weeks 5 to 8: The First Real Shift (0.5 mg Weekly)

This is typically when appetite suppression becomes noticeable. Many patients describe it as the background noise around food quieting down. The constant thoughts about eating, snacking, and what comes next simply fade. Average weekly weight loss at this stage is around 0.5 to 1 pound. Patients who are also prioritizing protein and reducing liquid calories tend toward the higher end.

Weeks 9 to 16: Momentum Phase (1.0 mg Weekly)

This is the period most people point to as when the medication truly clicked. Appetite suppression is operating fully, and the consistent calorie gap produces visible, measurable results. Average weekly loss in this window is 0.75 to 1.5 pounds, with some patients reaching 2 pounds per week if their diet has changed meaningfully.

Weeks 17 and Beyond: Steady Progress (1.7 to 2.4 mg Weekly)

For patients on Wegovy, doses continue escalating to 2.4 mg by around month five, which is the full therapeutic dose used in the STEP 1 trial. Weekly loss at this stage typically settles into a 0.5 to 1 pound pattern. Some people experience a plateau as the body adapts to the new baseline calorie intake. That is normal and expected.

How to Calculate Your Personal Weekly Target

Trial averages provide useful benchmarks, but your number depends on your specific biology. A standard calculation approach: a 500-calorie daily deficit produces approximately 1 pound of fat loss per week. Semaglutide naturally reduces calorie intake by 300 to 600 calories per day for most people through appetite suppression alone. When paired with intentional dietary choices, a total daily deficit of 700 to 1,000 calories is realistic for many patients, producing 1.5 to 2 pounds per week during the acceleration phase.

People who start at a higher BMI, above 40, often see faster absolute weekly losses because their total calorie burn is higher, creating a larger deficit in real numbers. Consistent high-protein intake, targeting 1.2 to 1.6 grams per kilogram of body weight daily, also accelerates fat-specific loss because it preserves lean muscle and keeps your resting metabolic rate from dropping.

What Can Slow Your Results

Liquid calories are the most common hidden barrier. Alcohol, flavored coffee drinks, fruit juice, and sweetened protein shakes can add hundreds of calories to your day without generating meaningful fullness. Semaglutide works partly by amplifying stretch-receptor signals in the stomach. Liquids largely bypass those receptors, meaning your brain never registers them the same way solid food does.

Thyroid conditions, significant insulin resistance, certain antidepressants, and corticosteroids can all reduce the metabolic effect. Getting fewer than six hours of sleep per night independently raises cortisol and ghrelin, which push back against appetite suppression. If your results feel slower than expected, discussing these factors with your physician before concluding the medication is not working is the right first step.

The Muscle Loss Issue That Deserves More Attention

The STEP 1 trial data contains a finding that receives far less attention than it should. Approximately 39 percent of the total weight lost by participants was lean body mass rather than fat. For someone who lost 30 pounds, roughly 12 pounds may have been muscle rather than fat.

Muscle burns calories at rest. Losing muscle during the weight loss phase lowers your resting metabolic rate, making results harder to maintain after treatment ends. It also affects strength, bone density, and long-term physical function.

This is largely preventable. The three interventions that protect muscle during semaglutide treatment are eating sufficient protein (target 1.2 to 1.6 grams per kilogram of body weight), performing resistance training at least three times per week, and for patients whose physicians recommend it, adding Sermorelin therapy to support overnight growth hormone production. Sermorelin is one of the most commonly paired therapies with GLP-1 medications at AHC for exactly this reason.

When the Plateau Arrives

At some point on semaglutide, the scale will stop moving for several weeks. This is not the medication failing. It is adaptive thermogenesis: your body lowering its own energy expenditure in response to a sustained calorie deficit. The same intake that produced a meaningful deficit in month two may produce a much smaller one by month six.

Most people hit their first significant plateau between months three and five. Practical approaches to move through it include a temporary period of eating at maintenance calories for five to seven days, increasing resistance training volume, reviewing protein intake, and improving sleep quality. If a plateau extends beyond six to eight weeks without an identifiable cause, requesting a thyroid and metabolic panel from your physician is a reasonable next step.

Frequently Asked Questions

1. How much weight do you lose in the first month on semaglutide?

Most people lose 2 to 5 pounds in the first month. The starting dose is a tolerance-building phase, not a fat-loss phase. Results typically accelerate from month two onward as the dose escalates.

2. Is losing 1 pound per week on Wegovy normal?

Yes. Losing 0.5 to 1.5 pounds per week at therapeutic doses is a healthy, sustainable pace. The STEP 1 trial averaged around 15 percent total body weight loss over 68 weeks, which works out to roughly 0.5 to 1 pound per week across the full treatment arc.

3. Why am I not losing weight on semaglutide?

The most common causes are being on the initial low dose, liquid calorie consumption, insufficient protein, poor sleep, or a metabolic plateau. Discussing these factors with your physician before assuming the medication is ineffective is worth doing first.

4. How long does it take to see results from semaglutide?

Reduced appetite typically appears within the first one to two weeks. Visible weight loss results tend to appear between weeks four and eight as the dose escalates past the starting 0.25 mg level.

5. What happens to your weight when you stop semaglutide?

Research shows that patients who stop semaglutide without maintained lifestyle habits regain approximately two-thirds of their lost weight within one year. The medication manages appetite neurologically, and stopping it removes that effect. Maintaining a high-protein diet, continuing resistance training, and discussing transition strategies with your physician significantly reduces rebound.

Start with the Right Protocol at AHC

AHC physicians build your full protocol: the right starting dose, a clear escalation plan, nutritional guidance, and the option to add Sermorelin to protect lean muscle throughout. Entirely online, at your schedule. Visit alternatehealthclub.com to book a free physician consultation.

Disclaimer: Compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality. All clinical services are provided by independently contracted, U.S.-licensed clinicians. Results vary by individual. This content is for informational purposes only and does not constitute medical advice.